US 10533171
Oligonucleotide comprising an inosine for treating DMD
granted A61KA61K48/00A61P
Quick answer
US patent 10533171 (Oligonucleotide comprising an inosine for treating DMD) held by BIOMARIN TECHNOLOGIES B.V. expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN TECHNOLOGIES B.V.
- Grant date
- Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K48/00, A61P, A61P21/00, A61P29/00